Literature DB >> 3007483

Scavenger receptor for aldehyde-modified proteins.

S Horiuchi, M Murakami, K Takata, Y Morino.   

Abstract

This paper describes an unexpectedly broad ligand specificity of a scavenger receptor of sinusoidal liver cells that is responsible for endocytic uptake of formaldehyde-treated bovine serum albumin (f-Alb). Binding of 125I-f-Alb to the isolated cells was effectively inhibited by bovine serum albumin (BSA) modified with aliphatic aldehydes such as glycolaldehye, DL-glyceraldehyde, and propionaldehyde whereas albumin preparations modified by aromatic aldehydes such as pyridoxal, pyridoxal phosphate, salicylaldehyde, and benzaldehyde did not affect this binding process. Binding of 125I-glycolaldehyde-treated BSA to the cells exhibited a saturation kinetics with an apparent Kd = 3.3 micrograms of the ligand/ml. This binding process was inhibited by unlabeled f-Alb as well as by the antibody raised against the f-Alb receptor. Indeed, 125I-glycolaldehyde-treated BSA underwent a rapid plasma clearance (t1/2 approximately 2 min) which was markedly retarded by unlabeled f-Alb. Upon treatment by these aldehydes, other proteins such as ovalbumin, soybean trypsin inhibitor, and hemoglobin were also converted to active ligands for the f-Alb receptor, while no ligand activity was generated with gamma-globulin and RNase A. These results clearly show that the f-Alb receptor, originally described as being specific for f-Alb, exhibits a broad ligand specificity in terms of both aldehydes and proteins and, hence, should be described as a scavenger receptor for aldehyde-modified proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Lipid peroxidation generates body odor component trans-2-nonenal covalently bound to protein in vivo.

Authors:  Kousuke Ishino; Chika Wakita; Takahiro Shibata; Shinya Toyokuni; Sachiko Machida; Shun Matsuda; Tomonari Matsuda; Koji Uchida
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

2.  Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

Authors:  S Kume; M Takeya; T Mori; N Araki; H Suzuki; S Horiuchi; T Kodama; Y Miyauchi; K Takahashi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

3.  Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia.

Authors:  S Wölle; D P Via; L Chan; J A Cornicelli; C L Bisgaier
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Methylglyoxal, glyoxalases and the development of diabetic complications.

Authors:  P J Thornalley
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

5.  Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins.

Authors:  M E Westwood; P J Thornalley
Journal:  J Protein Chem       Date:  1995-07

6.  Malondialdehyde-acetaldehyde (MAA) adducted proteins bind to scavenger receptor A in airway epithelial cells.

Authors:  John P Berger; Samantha M Simet; Jane M DeVasure; Jessica A Boten; Jenea M Sweeter; Kusum K Kharbanda; Joseph H Sisson; Todd A Wyatt
Journal:  Alcohol       Date:  2014-05-11       Impact factor: 2.405

7.  Immunohistochemical localization of apolipoprotein E in human glial neoplasms.

Authors:  M Murakami; Y Ushio; Y Morino; T Ohta; Y Matsukado
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

8.  Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity.

Authors:  T Shcheglova; S P Makker; A Tramontano
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

9.  Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.

Authors:  Z Yang; Z Makita; Y Horii; S Brunelle; A Cerami; P Sehajpal; M Suthanthiran; H Vlassara
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells.

Authors:  Geoffrey M Thiele; Michael J Duryee; Monte S Willis; Michael F Sorrell; Thomas L Freeman; Dean J Tuma; Lynell W Klassen
Journal:  Comp Hepatol       Date:  2004-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.